Cas 905858-53-9,(S)-2-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester

905858-53-9

Post Buying Request

Basic information

Product Name: (S)-2-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
Synonyms: (S)-2-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
CAS NO:905858-53-9
Molecular Formula:
Molecular Weight: 375.468
EINECS: N/A
Product Categories: N/A
Mol File: 905858-53-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-2-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: (S)-2-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester(905858-53-9)
EPA Substance Registry System: (S)-2-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester(905858-53-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 905858-53-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

905858-53-9 Suppliers

Recommended suppliersmore

905858-53-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 905858-53-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,8,5 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 905858-53:
(8*9)+(7*0)+(6*5)+(5*8)+(4*5)+(3*8)+(2*5)+(1*3)=199
199 % 10 = 9
So 905858-53-9 is a valid CAS Registry Number.

905858-53-9Upstream product

905858-53-9Downstream Products

905858-53-9Relevant articles and documents

Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds

Gilleron,Millet,Houssin,Wlodarczyk,Farce,Lemoine,Goossens,Chavatte,Pommery,Henichart

, p. 745 - 755 (2007/10/03)

Oncogenic Ras proteins whose activation is farnesylation by farnesyltransferase have been seen as important targets for novel anticancer drugs. Inhibitors of this enzyme have already been developed as potential anti-cancer drugs, particularly by rational

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 905858-53-9